A single session of intermittent hypoxia acutely reduces cortisol and leptin while increasing adiponectin levels in people with Parkinson's disease, without disrupting sleep behavior.
In a randomized, double-blind, crossover trial, 15 people with Parkinson's disease (pwPD) and 15 healthy controls underwent one session of intermittent hypoxia (IH) or normoxia. IH acutely decreased cortisol and leptin and increased adiponectin in pwPD, with no significant changes in BDNF, IL-6, or iron. No effects on sleep parameters were observed immediately post-IH, but total sleep time decreased 24 hours after IH versus the immediate post-session measurement in pwPD.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
A single session of intermittent hypoxia acutely reduces cortisol and leptin while increasing adiponectin levels in people with Parkinson's disease, without disrupting sleep behavior. The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
A single session of intermittent hypoxia acutely reduces cortisol and leptin while increasing adiponectin levels in people with Parkinson's disease, without disrupting sleep behavior.
This conclusion is most relevant to: 15 people with Parkinson's disease and 15 sex-matched neurologically healthy individuals..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸The acute effects of a single session of intermittent hypoxia on blood biomarker concentrations and sleep parameters in people with Parkinson's disease: A randomized, double-blind, crossover trial. (Parkinsonism & related disorders, 2026) —
How It Works
The proposed biological pathway:
- ▸Intermittent hypoxia induces a hypoxic dose (SpO2 reduction 5-20%) and activates physiological responses.
- ▸Hypoxia modulates endocrine and metabolic pathways, leading to decreased cortisol and leptin and increased adiponectin.
- ▸These biomarker changes occur without acute disruption of sleep parameters.
- ▸Result: IH acutely alters specific biomarkers in pwPD, suggesting potential neuroprotective or metabolic effects.
Who Might Benefit
Evidence fit by population:
- ▸15 people with Parkinson's disease and 15 sex-matched neurologically healthy individuals.
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Small sample size (15 per group) limits generalizability.
- ▸Only acute and 24-hour effects were assessed; long-term effects and clinical significance remain unknown.
- ▸Sleep parameters were measured via actigraphy, not polysomnography, which may miss subtle changes.
- ▸The study did not assess subjective sleep quality or daytime symptoms.
Frequently Asked Questions
What is intermittent hypoxia and how was it applied in this study?▼
Intermittent hypoxia (IH) involves brief episodes of reduced oxygen levels. In this study, participants breathed 10% oxygen for 6 minutes, repeated four times, with 5-minute normoxic breaks, totaling 39 minutes.
Did intermittent hypoxia affect sleep in people with Parkinson's disease?▼
No immediate effects on sleep parameters were observed after IH compared to baseline. However, total sleep time decreased 24 hours after IH compared to the immediate post-session measurement, but this was not compared to normoxia.
Which blood biomarkers changed after intermittent hypoxia?▼
In people with Parkinson's disease, IH acutely reduced cortisol and leptin levels and increased adiponectin levels. No significant changes were found in BDNF, IL-6, or iron.
Is intermittent hypoxia safe for people with Parkinson's disease?▼
The study reports that a single session of IH was safe and effective in inducing hypoxia without disrupting sleep behavior. However, longer-term safety and effects require further investigation.
References
- 1.Faria MH, Kalva-Filho CA, Queiroz VO, Boonstra TW, de Oliveira M, Cursiol JA, Schlenstedt C, Lira FS, Antunes BM, Barbieri FA. “The acute effects of a single session of intermittent hypoxia on blood biomarker concentrations and sleep parameters in people with Parkinson's disease: A randomized, double-blind, crossover trial..” Parkinsonism & related disorders, 2026. PMID: 42574864 DOI: 10.1016/j.parkreldis.2026.108922